Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Salmonella as a tumour medication

23.10.2017

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target tumours and to colonise them. Researchers are aiming to make use of this property for cancer therapy, but they are facing a dilemma:


Electron microscopic image of Salmonella enterica (serovar Typhimurium).

HZI/Manfred Rohde

Salmonella infections are life-threatening. Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig now undertook a successful step towards the clinical application. They developed a Salmonella strain that induces only a harmless infection, but activates the immune system strongly enough to fight the tumours. Their results were published in the journal OncoImmunology.

Cancer diseases are some of the most common causes of death throughout the world, and they are still gaining in significance as the average general population gets older. However, we still do not have a satisfactory therapy for many types of tumours. One extremely promising approach is to involve the immune system in the control of the tumour.

Scientists from the HZI use Salmonella enterica bacteria to activate the immune system to tumours and to trigger an inherent defence reaction. In cancer patients, salmonellae colonise tumour tissue specifically, but the infection can take a life-threatening course. "For this type of tumour therapy, a strain of Salmonella must not only trigger a strong defence reaction of the immune system, but it must also not be too aggressive such that we can keep it in check," says Dr Sebastian Felgner, who is a scientist at the HZI.

The HZI researchers introduced genetic changes into the bacteria step-by-step and tried to find an optimal balance between safety and sufficient immune activation. "We changed numerous properties of the salmonellae, for example a component that eliminates the apparatus of motility and therefore restricts the mobility of the bacteria," says Felgner.

In order to increase the visibility of the bacteria to the immune system, the scientists also addressed certain other molecules in the membrane – which is the outer shell – of the salmonellae. This is where so called lipopolysaccharides consisting of sugar chains and lipid chains are anchored. These molecules reside on the surface of the bacteria and are recognised by the immune system as being foreign.

To hide themselves upon infection, salmonellae have a number of enzymes that cleave lipid chains as soon as they enter the host. "We switched off those cleaving enzymes in our Salmonella strain. As a result, the lipid chains on the surface of the bacteria are preserved in the patients and are quite visible to the immune system," says Felgner.

Following this scheme, the scientists introduced a number of other genetic modifications into their Salmonella strain and investigated the therapeutic effect in mice. In the course of this work, they successfully found a proper balance between attenuation of the bacteria and the intensity of the immune reaction, and even took another hurdle:

"One problem is that humans that have been exposed previously to the bacteria developed immunity against them and may possibly no longer respond to the therapeutic salmonellae," says Dr Siegfried Weiß, the former head of the "Molecular Immunology" department of the HZI, who now works at the Hannover Medical School. "Therefore, a therapeutic strain must be able to overcome this inherent protection of the body, since salmonella infections are rather common, especially in countries with poor hygienic conditions where large parts of the population are immune."

The numerous modifications introduced by the HZI researchers have now resulted in a Salmonella strain that mobilises the inherent defence even in mice that are immune to salmonellae. "Even tumours that used to be resistant to the strain are now eliminated by the immune system," says Weiß.

The research is being done in close cooperation with the "Infection Biology of Salmonella" young investigator group of Prof Marc Erhardt, who recently joined the Humboldt University in Berlin. A patent for the newly developed Salmonella strain has been filed. "Our strain is safe and at the same time effective enough for tumour therapy," says Sebastian Felgner. "The next step towards therapeutic application would be to test the strain in clinical studies in cooperation with industrial partners and to check its suitability for clinical application."

Original publication:
Sebastian Felgner, Dino Kocijancic, Michael Frahm, Ulrike Heise, Manfred Rohde, Kurt Zimmermann, Christine Falk, Marc Erhardt, and Siegfried Weiss: Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy. OncoImmunology, 2017, DOI: 10.1080/2162402X.2017.1382791

The press release and a picture are also available on our website: https://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/salmonell...

Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, are engaged in the study of different mechanisms of infection and of the body’s response to infection. Helping to improve the scientific community’s understanding of a given bacterium’s or virus’ pathogenicity is key to developing effective new treatments and vaccines. http://www.helmholtz-hzi.de/en

Contact:
Susanne Thiele, Press Officer
susanne.thiele@helmholtz-hzi.de
Dr Andreas Fischer, Editor
andreas.fischer@helmholtz-hzi.de

Helmholtz Centre for Infection Research
Press and Communications
Inhoffenstr. 7
D-38124 Braunschweig
Germany

Phone: +49 531 6181-1404

Susanne Thiele | Helmholtz-Zentrum für Infektionsforschung

More articles from Life Sciences:

nachricht Barium ruthenate: A high-yield, easy-to-handle perovskite catalyst for the oxidation of sulfides
16.07.2018 | Tokyo Institute of Technology

nachricht The secret sulfate code that lets the bad Tau in
16.07.2018 | American Society for Biochemistry and Molecular Biology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Subaru Telescope helps pinpoint origin of ultra-high energy neutrino

16.07.2018 | Physics and Astronomy

Barium ruthenate: A high-yield, easy-to-handle perovskite catalyst for the oxidation of sulfides

16.07.2018 | Life Sciences

New research calculates capacity of North American forests to sequester carbon

16.07.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>